2009
DOI: 10.1186/1752-0509-3-52
|View full text |Cite
|
Sign up to set email alerts
|

Proteomic and network analysis characterize stage-specific metabolism in Trypanosoma cruzi

Abstract: BackgroundTrypanosoma cruzi is a Kinetoplastid parasite of humans and is the cause of Chagas disease, a potentially lethal condition affecting the cardiovascular, gastrointestinal, and nervous systems of the human host. Constraint-based modeling has emerged in the last decade as a useful approach to integrating genomic and other high-throughput data sets with more traditional, experimental data acquired through decades of research and published in the literature.ResultsWe present a validated, constraint-based … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
49
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(49 citation statements)
references
References 71 publications
0
49
0
Order By: Relevance
“…99%Used to constrain CBMs [12, 13]; reviewed in [44]Proteomics2D LC-MS/MS [45], nano-LC-MS/MS [46]ca. 45%Used to constrain CBMs [47]MetabolomicsHPLC-MS/MS [30, 48], 1 H-NMR [49]ca. 15-20%Used to constrain CBMs [32, 34], reviewed in [33]Fluxomics 13 C-NMR [50, 51], 14 C-NMR [52]Less than 1%Used to constrain CBMs, reviewed in [53, 54]…”
Section: High-throughput Data and Metabolic Models: ‘Content For Contmentioning
confidence: 99%
“…99%Used to constrain CBMs [12, 13]; reviewed in [44]Proteomics2D LC-MS/MS [45], nano-LC-MS/MS [46]ca. 45%Used to constrain CBMs [47]MetabolomicsHPLC-MS/MS [30, 48], 1 H-NMR [49]ca. 15-20%Used to constrain CBMs [32, 34], reviewed in [33]Fluxomics 13 C-NMR [50, 51], 14 C-NMR [52]Less than 1%Used to constrain CBMs, reviewed in [53, 54]…”
Section: High-throughput Data and Metabolic Models: ‘Content For Contmentioning
confidence: 99%
“…Figure 1 and Example 1 are from a manually constructed mammalian network database, available at PathCase-MAW site. 14 All other examples and visualizations in figures of this paper are obtained from the PathCase-RCMN (ReConstructed genome-scale Metabolic Network) application, 15 which is, in turn, built by importing the SBML of reconstructed metabolic network of Trypanosoma cruzi bacteria: 16 The SMDA tool, an evolution of the OMA Tool, 17 is currently being beta-tested in cystic fibrosis metabolomics data analysis.…”
Section: Introductionmentioning
confidence: 99%
“…The integration of genomic and physiological information is now increasingly important with the emergence of "systems biology", which attempts to simultaneously study the expression patterns and activity of all genes, together with proteomic and metabolomic data [Cavalieri and Filippo, 2005]. When combined with a specific method of analysis like flux balance analysis (FBA), constraint-based models can be used to generate quantitative predictions (e.g., growth rate of an organism) and yield testable hypotheses for future experimental investigations [Roberts et al, 2009;Lee et al, 2006]. This permits an iterative process of model development, hypothesis generation and testing, and further model development and refinement [Reed et al, 2006].…”
Section: Wwwintechopencommentioning
confidence: 99%